Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

AntimiR-155 Cyclic Peptide-PNA Conjugate: Synthesis, Cellular Uptake, and Biological Activity.

Soudah T, Khawaled S, Aqeilan RI, Yavin E.

ACS Omega. 2019 Aug 12;4(9):13954-13961. doi: 10.1021/acsomega.9b01697. eCollection 2019 Aug 27.

2.

MiR-16-1-3p and miR-16-2-3p possess strong tumor suppressive and antimetastatic properties in osteosarcoma.

Maximov VV, Akkawi R, Khawaled S, Salah Z, Jaber L, Barhoum A, Or O, Galasso M, Kurek KC, Yavin E, Aqeilan RI.

Int J Cancer. 2019 Dec 1;145(11):3052-3063. doi: 10.1002/ijc.32368. Epub 2019 May 9.

PMID:
31018244
3.

WWOX Inhibits Metastasis of Triple-Negative Breast Cancer Cells via Modulation of miRNAs.

Khawaled S, Suh SS, Abdeen SK, Monin J, Distefano R, Nigita G, Croce CM, Aqeilan RI.

Cancer Res. 2019 Apr 15;79(8):1784-1798. doi: 10.1158/0008-5472.CAN-18-0614. Epub 2019 Jan 8.

PMID:
30622118
4.

Microenvironmental Cues Determine Tumor Cell Susceptibility to Neutrophil Cytotoxicity.

Gershkovitz M, Fainsod-Levi T, Khawaled S, Shaul ME, Sionov RV, Cohen-Daniel L, Aqeilan RI, Shaul YD, Fridlender ZG, Granot Z.

Cancer Res. 2018 Sep 1;78(17):5050-5059. doi: 10.1158/0008-5472.CAN-18-0540. Epub 2018 Jul 2.

5.

TRPM2 Mediates Neutrophil Killing of Disseminated Tumor Cells.

Gershkovitz M, Caspi Y, Fainsod-Levi T, Katz B, Michaeli J, Khawaled S, Lev S, Polyansky L, Shaul ME, Sionov RV, Cohen-Daniel L, Aqeilan RI, Shaul YD, Mori Y, Karni R, Fridlender ZG, Binshtok AM, Granot Z.

Cancer Res. 2018 May 15;78(10):2680-2690. doi: 10.1158/0008-5472.CAN-17-3614. Epub 2018 Feb 28.

6.

Combined shRNA over CRISPR/cas9 as a methodology to detect off-target effects and a potential compensatory mechanism.

Peretz L, Besser E, Hajbi R, Casden N, Ziv D, Kronenberg N, Gigi LB, Sweetat S, Khawaled S, Aqeilan R, Behar O.

Sci Rep. 2018 Jan 8;8(1):93. doi: 10.1038/s41598-017-18551-z.

7.

Hyperglycemia Impairs Neutrophil Mobilization Leading to Enhanced Metastatic Seeding.

Fainsod-Levi T, Gershkovitz M, Völs S, Kumar S, Khawaled S, Sagiv JY, Sionov RV, Grunewald M, Keshet E, Granot Z.

Cell Rep. 2017 Nov 28;21(9):2384-2392. doi: 10.1016/j.celrep.2017.11.010.

8.

RUNX1, a new regulator of EMT in breast cancer.

Khawaled S, Aqeilan RI.

Oncotarget. 2017 Mar 14;8(11):17407-17408. doi: 10.18632/oncotarget.15623. No abstract available.

9.

miR-27a and miR-27a* contribute to metastatic properties of osteosarcoma cells.

Salah Z, Arafeh R, Maximov V, Galasso M, Khawaled S, Abou-Sharieha S, Volinia S, Jones KB, Croce CM, Aqeilan RI.

Oncotarget. 2015 Mar 10;6(7):4920-35.

10.

MiR-520d-5p directly targets TWIST1 and downregulates the metastamiR miR-10b.

Tsukerman P, Yamin R, Seidel E, Khawaled S, Schmiedel D, Bar-Mag T, Mandelboim O.

Oncotarget. 2014 Dec 15;5(23):12141-50.

11.

Characterization of WWOX inactivation in murine mammary gland development.

Abdeen SK, Salah Z, Khawaled S, Aqeilan RI.

J Cell Physiol. 2013 Jul;228(7):1391-6. doi: 10.1002/jcp.24310.

PMID:
23254778

Supplemental Content

Loading ...
Support Center